Publications by authors named "James Gahn"

Claim this Profile
H
HSR25-203: Cost-Effectiveness Evaluation of Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments Among Medicare Patients With Chronic Lymphocytic Leukemia (CLL) in First-Line (1L) and Relapsed/Refractory (R/R) Settings.
Samuel Crawford, Huimin Li, Bhavini Srivastava, Pam Martin, James Gahn

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unfavorable Outcomes Associated With Glucocorticoid Use in Current Standard-of-Care Management of Systemic Lupus Erythematosus in Canada.
Zahi Touma, Sheena Kayaniyil, Anna Parackal, Denisse Bonilla, Jiandong Su, James Gahn

ACR Open Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA.
Jing Voon Chen, James C Gahn, Jeffrey Nesheim, Paul N Mudd

Pharmacoeconomics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
Michelle Tew, Michael Willis, Christian Asseburg, Hayley Bennett, Alan Brennan, James Gahn

Med Decis Making· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Andrew J Palmer, Lei Si, Michelle Tew, Xinyang Hua, Michael S Willis, James C Gahn

Value Health· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Febuxostat in the management of gout: a cost-effectiveness analysis.
Lee J Smolen, James C Gahn, Ghaith Mitri, Aki Shiozawa

J Med Econ· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective.
Lee J Smolen, James C Gahn, Ghaith Mitri, Aki Shiozawa

Clin Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective.
Bradley H Curtis, Sarah Curtis, Daniel R Murphy, James C Gahn, Sinem Perk

J Med Econ· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
Harry J Smolen, Daniel R Murphy, James C Gahn, Xueting Yu, Bradley H Curtis

J Manag Care Spec Pharm· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.
Julie Myers, Ronald C Wielage, Baoguang Han, Karen Price, James Gahn

BMC Musculoskelet Disord· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model.
Nicolas M Furiak, James C Gahn, Robert W Klein, Stephen B Camper, Kent H Summers

Ann Gen Psychiatry· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis